{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:54:53Z","timestamp":1758048893158,"version":"3.44.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016126","name":"Beijing Hospitals Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016126","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.bbrc.2022.03.080","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T01:46:51Z","timestamp":1649900811000},"page":"176-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Methylation of the HCBP6 promoter is associated with primary biliary cholangitis pathogenesis"],"prefix":"10.1016","volume":"610","author":[{"given":"Lili","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2022.03.080_bib1","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bbrc.2022.03.080_bib2","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.bbrc.2022.03.080_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nrrheum.2013.211","article-title":"Epigenetics in 2013. DNA methylation and miRNA: key roles in systemic autoimmunity","volume":"10","author":"Richardson","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bbrc.2022.03.080_bib4","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/humu.20591","article-title":"Double complex mutations involving F8 and FUNDC2 caused by distinct break-induced replication","volume":"28","author":"Sheen","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbrc.2022.03.080_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13148-015-0098-9","article-title":"DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosis","volume":"7","author":"Lleo","year":"2015","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.bbrc.2022.03.080_bib6","first-page":"351","article-title":"Screening and cloning gene of hepatocyte protein interacting with hepatitis C virus core protein","volume":"16","author":"Li","year":"2002","journal-title":"Chin. J. Exp. Clin. Virol."},{"key":"10.1016\/j.bbrc.2022.03.080_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41418-018-0121-8","article-title":"Mitochondrial PIP3-binding protein FUNDC2 supports platelet survival via AKT signaling pathway","volume":"26","author":"Ma","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbrc.2022.03.080_bib8","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/jcb.25188","article-title":"HCBP6 modulates triglyceride homeostasis in hepatocytes via the SREBP1c\/FASN pathway","volume":"116","author":"Gao","year":"2015","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.bbrc.2022.03.080_bib9","doi-asserted-by":"crossref","first-page":"511","DOI":"10.5604\/01.3001.0011.7396","article-title":"HCBP6 is involved in the development of hepatic steatosis induced by high-fat diet and CCL4 in rats","volume":"17","author":"Zheng","year":"2018","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.bbrc.2022.03.080_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110347","article-title":"HCBP6 deficiency exacerbates glucose and lipid metabolism disorders in non-alcoholic fatty liver mice","volume":"129","author":"Lu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2022.03.080_bib11","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/cvr\/cvy311","article-title":"FUNDC2 regulates platelet activation through AKT\/GSK-3\u03b2\/cGMP axis","volume":"115","author":"Ma","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2022.03.080_bib12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMe1607744","article-title":"Primary biliary cholangitis--A new name and a new treatment","volume":"375","author":"Pratt","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2022.03.080_bib13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2249.2010.04288.x","article-title":"Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis","volume":"163","author":"Stinton","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbrc.2022.03.080_bib14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1751-2980.2011.00537.x","article-title":"Cytotoxic T-lymphocyte antigen 4 gene\u00a0+49A\/G polymorphism significantly associated with susceptibility to primary biliary cirrhosis: a meta-analysis","volume":"12","author":"Chen","year":"2011","journal-title":"J.\u00a0Digest. Dis."},{"key":"10.1016\/j.bbrc.2022.03.080_bib15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5114\/aoms.2011.23398","article-title":"Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis","volume":"7","author":"Selmi","year":"2011","journal-title":"Arch. Med. Sci. : AMS"},{"key":"10.1016\/j.bbrc.2022.03.080_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4161\/epi.6.1.13405","article-title":"Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis","volume":"6","author":"Mitchell","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.bbrc.2022.03.080_bib17","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/hep.24414","article-title":"Human leukocyte antigen in primary biliary cirrhosis: an old story now reviving","volume":"54","author":"Invernizzi","year":"2011","journal-title":"Hepatology (Baltimore, Md"},{"key":"10.1016\/j.bbrc.2022.03.080_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1399-0039.2011.01684.x","article-title":"Replicated association of 17q12-21 with susceptibility of primary biliary cirrhosis in a Japanese cohort","volume":"78","author":"Tanaka","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bbrc.2022.03.080_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1665-2681(19)31481-4","article-title":"Smoking as a risk factor for autoimmune liver disease: what we can learn from primary biliary cirrhosis","volume":"11","author":"Smyk","year":"2012","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.bbrc.2022.03.080_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaut.2012.03.001","article-title":"Subgroups of Sj\u00f6gren syndrome patients according to serological profiles","volume":"39","author":"Bournia","year":"2012","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.bbrc.2022.03.080_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3347\/kjp.2012.50.2.133","article-title":"Visceral leishmaniasis mimicking autoimmune hepatitis, primary biliary cirrhosis, and systemic lupus erythematosus overlap","volume":"50","author":"Tunccan","year":"2012","journal-title":"Kor. J. Parasitol."},{"key":"10.1016\/j.bbrc.2022.03.080_bib22","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1097\/MCG.0b013e318261e659","article-title":"Primary biliary cirrhosis is more severe in overweight patients","volume":"47","author":"H\u00edndi","year":"2013","journal-title":"J.\u00a0Clin. Gastroenterol."},{"key":"10.1016\/j.bbrc.2022.03.080_bib23","doi-asserted-by":"crossref","first-page":"959","DOI":"10.11569\/wcjd.v11.i7.959","article-title":"Up-regulating effect of human hepatitis C virus core protein-binding protein 6 on NACA promoter","volume":"11","author":"Qian Y","year":"2003","journal-title":"World Chin. J. Dig."},{"key":"10.1016\/j.bbrc.2022.03.080_bib24","first-page":"81","article-title":"Identification and evaluation promoter sequence and the transcription activation of Hcbp6 interaction with core protein of hepatitis C virus","volume":"14","author":"Wang","year":"2006","journal-title":"Chin. J. Hepatol."},{"key":"10.1016\/j.bbrc.2022.03.080_bib25","first-page":"128","article-title":"Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis","volume":"5","author":"Selmi","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2022.03.080_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature14192","article-title":"Function and information content of DNA methylation","volume":"517","author":"Sch\u00fcbeler","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2022.03.080_bib27","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrg3230","article-title":"Functions of DNA methylation: islands, start sites, gene bodies and beyond","volume":"13","author":"Jones","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbrc.2022.03.080_bib28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrg1925","article-title":"Insulators: exploiting transcriptional and epigenetic mechanisms","volume":"7","author":"Gaszner","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbrc.2022.03.080_bib29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2217\/epi.15.39","article-title":"Methyl-CpG-binding domain proteins: readers of the epigenome","volume":"7","author":"Du","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.bbrc.2022.03.080_bib30","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nrg3270","article-title":"DNA methylation profiling in the clinic: applications and challenges","volume":"13","author":"Heyn","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbrc.2022.03.080_bib31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/cmi.2010.78","article-title":"The epigenetics of autoimmunity","volume":"8","author":"Meda","year":"2011","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbrc.2022.03.080_bib32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaut.2013.07.004","article-title":"Novel insights into autoimmune liver diseases provided by genome-wide association studies","volume":"46","author":"Mells","year":"2013","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.bbrc.2022.03.080_bib33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hep.21696","article-title":"Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis","volume":"46","author":"Miozzo","year":"2007","journal-title":"Hepatology (Baltimore, Md"},{"key":"10.1016\/j.bbrc.2022.03.080_bib34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12072-017-9830-1","article-title":"Primary biliary cholangitis: a comprehensive overview","volume":"11","author":"Lleo","year":"2017","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.bbrc.2022.03.080_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.01.010","article-title":"The critical importance of epigenetics in autoimmunity","volume":"41","author":"Lu","year":"2013","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.bbrc.2022.03.080_bib36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hep.24630","article-title":"Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis","volume":"55","author":"Lleo","year":"2012","journal-title":"Hepatology (Baltimore, Md"},{"key":"10.1016\/j.bbrc.2022.03.080_bib37","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1182\/blood-2010-03-274241","article-title":"Different molecular behavior of CD40 mutants causing hyper-IgM syndrome","volume":"116","author":"Lanzi","year":"2010","journal-title":"Blood"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22004132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22004132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:18:41Z","timestamp":1757765921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X22004132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":37,"alternative-id":["S0006291X22004132"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.03.080","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methylation of the HCBP6 promoter is associated with primary biliary cholangitis pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.03.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}